StubHub reiterates 2026 outlook for $9.9B-$10.1B GMS and $400M-$420M adjusted EBITDA as margins expand (NYSE:STUB)May 14, 2026
StubHub reiterates 2026 outlook for $9.9B-$10.1B GMS and $400M-$420M adjusted EBITDA as margins expand (NYSE:STUB)May 14, 2026
Insight Molecular Diagnostics expects about $0.25M Q2 2026 revenue while projecting second-quarter cash burn above $9M (NASDAQ:IMDX)May 14, 2026